Don’t miss the latest developments in business and finance.

Home / India News / Lupin receives USFDA final approval for generic Temovate Cream, 0.05%

Lupin receives USFDA final approval for generic Temovate Cream, 0.05%

Image
Capital Market
Last Updated : Feb 01 2018 | 7:31 PM IST
Connect with us
Facebook IconLinkedIN Icon
Lupin has received final approval for its Clobetasol Propionate Cream USP, 0.05% from the USFDA to market a generic version of Fougera Pharmaceuticals Inc's Temovate Cream, 0.05%.

Powered by Capital Market - Live News

Connect with us on WhatsApp

Also Read

Lupin gets USFDA nod to market its skin conditions cream

Strides Shasun gets USFDA nod for two products

Strides Shasun receives approval for Nystatin and Triamcinolone Acetonide Ointment

Sun Pharma gains after USFDA accepts new drug application

Insecticides India to announce Quarterly Result

First Published: Feb 01 2018 | 7:16 PM IST

Explore News

Next Story